Wnt Signaling

Advertisement

cGxPJobs Banner

Iterion Therapeutics Reports Positive Tegavivint Phase 1b Data

Houston, Texas, U.S., September 22, 2026 Iterion Therapeutics has announced promising results from a Phase 1b clinical study evaluating...

By cGxPwire Editor
September 25, 2026

Read More

Advertisement

cGxPJobs

Directory